ABOUT SENETEK

At Senetek we recognize the importance of addressing the issues of an aging population.   With an emphasis on safety and efficacy, we have developed breakthrough technologies that target the science of healthy aging and improve the lives of millions of people worldwide. 

Senetek’s extensive research collaborations have resulted in a strong pipeline of patented compounds with broad therapeutic applications and a leading presence in dermatology. Senetek scientists led the way to discover the best-selling anti-aging ingredient in the North American physician market and now the Company is poised to launch new products with even greater promise within their therapeutic categories.  In early 2008, Senetek will introduce a new classification of cytokinin to the ethical market that has shown attributes more beneficial to treatment than any predecessor compound.   With strong partnerships and expanded financial resources, the company is now positioned to accelerate development of these compounds as well as other important technologies from our rich IP portfolio.   

Our scientific environment is collaborative and entrepreneurial.  Senetek’s scientific collaborations form the basis for an interactive flow of new product identification, evaluation, and testing activity among renowned research institutions in the U.S. and Europe.

Senetek collaborates with leading pharmaceutical companies in the development and marketing of our products. Successful commercial partnerships grant the Company an expansive network of resources through which we have accelerated the development of our technology.